Evidence map›Paper›PMID 38789914›Full record

ArticleHormones (Athens, Greece)2024

A variant of uncertain significance of the HMGA2 gene in a child with Silver-Russell syndrome-like phenotype: a case report.

Evangelos Bourousis, Maria Xatzipsalti, Ioulia Polychroni, Emmanouil Kanavakis, Lela Stamoyannou

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Hormones (Athens, Greece), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Evangelos BourousisChild's & Adolescent's Development and Endocrinology Unit, Athens General Children's Hospital "P. & A. Kyriakou", Athens, Greece. vbourousis@gmail.com.ORCID http://orcid.org/0000-0001-5638-9439
Maria XatzipsaltiChild's & Adolescent's Development and Endocrinology Unit, Athens General Children's Hospital "P. & A. Kyriakou", Athens, Greece.
Ioulia PolychroniPrivate Endocrinology Unit, Athens, Greece.
Emmanouil KanavakisGenesis Genoma" Lab, Private Clinical Genetics Lab, Athens, Greece.
Lela StamoyannouSpecial Child's & Adolescent's Development and Endocrinology Unit, "IASO" Children's Private Hospital, Athens, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Silver-Russell syndrome 5 (SRS5) is characterized by asymmetric intrauterine growth restriction (IUGR), poor postnatal growth, macrocephaly at birth, and feeding difficulties. Other possible features include triangular shaped face, prominent forehead, hypertelorism, epicanthus, micrognathia, brachydactyly, clinodactyly of the 5th finger, and syndactyly of the 2nd and 3rd toes. Pathogenic variants of the HMGA2 (high mobility group AT-hook 2) gene, on chromosome 12q14, which regulates the transcription of growth factor IGF2, have recently been associated with this syndrome. Herein, we present a 2.5-year-old boy with growth delay, SRS-like phenotype, and a variant of uncertain significance in the HMGA2 gene, which has not, to the best of our knowledge, been described to date in the medical literature. So far, 28 pathogenic variants of the HMGA2 gene in patients with clinical SRS phenotype have recently been reported. Therefore, HMGA2 gene testing should always be done in SRS patients who are found to be negative for the typical 11p15 (epi)mutations and matUPD7, while the mutations should also be added to growth retardation disorder panels.

Indexed as

HMGA2 ProteinPhenotypeSilver-Russell SyndromeChild, PreschoolHumansMaleHMGA2 ProteinHMGA2 protein, humanGeneHMGA2MutationNovelSilver RussellSyndrome

Identifiers

PMID38789914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.